Bachem Holding AG (FRA:BHM) Net Interest Margin (Bank Only) %


FRA:BHM Bachem Holding AG FRA:BHM
76 GF Score
Price €8.40
GF Value €9.28
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bachem Holding AG Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:BHM
76GF Score
Bachem Holding AG FRA:BHM
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bachem Holding AG (FRA:BHM) Overvalued in 2026?

Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued. The current stock price of €8.40 is trading 9.5% below its estimated GF Value™ of €9.28. GuruFocus considers Bachem Holding AG to be Fairly Valued.

Key valuation signals for FRA:BHM:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €9.28 vs. price of €8.40 (9.5% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:BHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bachem Holding AG Business Description

Address Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
76GF Score

Get the complete analysis for FRA:BHM

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.40
Price
€9.28
GF Value